Arthritis is a chronic condition caused by inflammation in the joints.
Reparagen, a dietary supplement manufactured and marketed by Park Labs, is a natural supplement designed to facilitate joint health through a type of gene therapy. The two main compounds in Reparagen act on the genes responsible for joint tissue degeneration and assist in the regeneration of joint tissue. Because of this regenerative function, Reparagen is seen to be at the forefront of medical developments in joint health.
Effects
Reparagen's main function is reduce inflammation in the joints and rebuild cartilage tissue. According to Park Labs and clinical trials conducted by Komal Mehta of Vedic Lifesciences and Dr. Mark Miller of the Center for Cardiovascular Sciences at Albany Medical Center, Reparagen has no known side effects, either in its complete formula or as a result of either of the two main ingredients of the supplement. The manufacturer also claims that Reparagen does not have any known interactions with other dietary supplements or drugs available over the counter or with a prescription.
Benefits
In addition to the advertised benefits of facilitating joint health through regenerating cartilage tissue, the makers of Reparagen also speculate that the supplement could help prevent the negative side effects of other anti-inflammatory drugs. Anti-inflammatory drugs can upset the stomach and potentially cause ulcers or other damage to the stomach, and Reparagen's natural ingredients may protect against these side effects.
Active Ingredients
The active ingredients of Reparagen are two plant extracts from South America: Vincaria, which comes from a vine in Amazon rainforests, and RNI-249, which comes from a turnip-like potato found only in the Andes Mountains. These natural ingredients regulate the genetic causes of inflammation and related joint pain, and have not been found to have any adverse side effects among those participating in clinical trials. Furthermore, these ingredients have not been found to upset the stomach and do not need to be taken in conjunction with food.
History
Reparagen was developed by Dr. Miller, a pharmaceutical industry researcher and consultant for the supplement's manufacturer, Park Labs. Miller conducted randomized, controlled clinical trials in 2007 that found Reparagen to be effective among 94 percent of test subjects and reported no observable side effects. While Reparagen is a relatively new product, research on its effects and related gene therapies for joint health is ongoing and can expect to generate new insights in the future.
Considerations
Reparagen is a dietary supplement, not a drug, and as such belongs to a class of health products that are not evaluated by the Food and Drug Administration (FDA). The FDA has not approved the ingredients of Reparagen or verified any claims made by the manufacturer regarding effectiveness or safety.
Tags: joint health, clinical trials, Park Labs, side effects, been found
